Use of stem cell factor and soluble interleukin-6 receptor for the ex vivo expansion of hematopoietic multipotential cells
Patent Number: 5861315
Date of First Priority Issue: Wednesday November 16th, 1994
Date Issued: Tuesday January 19th, 1999
Assignee: Amgen Inc. (Thousand Oaks, CA); Tosoh Corporation (Thousand Oaks, CA)
Inventor: Nakahata, Tatsutoshi (Tokyo, JP)
From Class: Expansion
Comments: No comments
This patent covers the use of the c-kit ligand together with stimulators of gp130 for the in vitro and ex vivo expansion of hematopoietic stem cells. Since the c-kit ligand is important for other types of stem cells, it will be interesting to see if this patent can be used for expansion of, say for example, cardiac stem cells.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.